Get started

Pennystocks

Bullish Charts - Golden Cross, July 6 Conf CallObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. On 06/29/20, ObsEva announced it will hold a conference call to discuss results from Phase 3 PRIMROSE 1 and PRIMROSE 2 clinical trials evaluating their drug Linzagolix in women with Uterine Fibroids. I personally think the conference call will be Bullish because on 07/01/20, ObsEva and Yuyuan BioScience Technology announced submission of the PRE-IND Dossier for Nolasiban with Chinese NMPA. This company has a few things going on that could be a catalyst for the stock moving into July 6, next week. Daily Chart is Bullish 50-Day MA just crossed up above the 200-Day MA - I believe this cross just happened today on above average volume. MACD is turning up, Bullish RSI is Bullish Stochastic is Bullish The Cloud indicators are all Bullish as seen below. 8-May-20 3.36 Bullish Kumo Breakout 5-May-20 2.95 Bullish Senkou Span Cross 4-May-20 2.41 Bullish Kijun Sen Cross 29-Apr-20 2.55 Bullish Tenkan/Kijun Cross 20-Apr-20 2.10 Bullish Chikou Span Cross Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
OLong
by HotCharts
1
Electric Vehicles - SOLO EV, Huge Potential, Deliveries Soon!Electrameccanica Vehicles Corp., a development-stage company, plans, develops, manufactures, and sells electric vehicles under the SOLO name. The company operates in two segments, Electric Vehicles and Custom Build Vehicles. It also has two other electric vehicle candidates under the design development stage, including Super SOLO and Tofino. It also develops and manufactures custom built vehicles. The company sells its vehicles online through electrameccanica.com Website, as well as through corporate owned stores. Electrameccanica Vehicles Corp. was incorporated in 2015 and is headquartered in Vancouver, Canada. The SOLO niche market could be gigantic especially in high tourism states, cities, towns and around the world. I think this stock has huge potential. See article link below. electrek.co On 06/16/2020, Electra announced the accelerated expansion of the company's retail footprint for its flagship SOLO EV with new locations planned for Arizona and Oregon. The company currently maintains a SOLO EV storefront at Westfield Century City in Los Angeles with a second location under contract at Westfield Fashion Square, a shopping center in Sherman Oaks, CA. Electra said "Production for existing orders remains on target and they expect to begin deliveries of SOLO to U.S. customers starting this fall." When you look at stocks like Workhorse (WKHS) and Tortoise (SHLL), who have not even started deliveries, SOLO is undervalued. I think the market for SOLO is huge especially in highly populated cities like New York and Boston where parking is hard to find. Currently, the stock has Bullish fundamentals. See below 2-Jul-20 3.13 ▲ Thu SOLO New York 29-Jun-20 2.56 Bullish Tenkan/Kijun Cross Strong 29-Jun-20 2.56 Bullish " Bullish Kijun Sen Cross Strong 25-Jun-20 1.91 Bullish Senkou Span Cross Strong 8-Jun-20 1.65 Bullish Kumo Breakout 21-May-20 1.06 Bullish Chikou Span Cross Again, the big game changer here, SOLO in my opinion has a niche market that could explode in orders moving forward. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
SLong
by HotCharts
1
Bullish Charts - Golden Cross, Facebook Shuts Down HobbiPinterest, Inc. provides visual discovery engine in the United States and internationally. The company's engine allows people to find inspiration for their lives, including recipes, home and style ideas, travel destinations, and others. It shows them visual recommendations based on people personal taste and interests. The company was formerly known as Cold Brew Labs Inc. and changed its name to Pinterest, Inc. in April 2012. Pinterest, Inc. was founded in 2008 and is headquartered in San Francisco, California. On 07/01/20, news hit the wires that said Facebook confirmed it was shutting down its rival website / app Hobbi leaving Pinterest with great potential & almost no competition. With Short Sellers controlling around 5.54% of the stock, and the news that Facebook is shutting down its rival app, I think this stock could easily run and possibly double in price. Daily Chart is Bullish The 50-Day MA just crossed up above the 200-Day MA Volume, MACD, RSI, Stochastic and Accumulation are all Bullish The Cloud is Bullish - Indicators listed below. 12-Jun-20 20.89 Bullish Chikou Span Cross Strong 29-May-20 20.29 Bullish Tenkan/Kijun Cross Strong 26-May-20 19.50 Bullish Kijun Sen Cross Strong 26-May-20 19.50 Bullish Kumo Breakout 27-Apr-20 20.78 Bullish Senkou Span Cross Strong PINS could be the only play in town for what it has and does. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:PINSLong
by HotCharts
KNOS ascending triangle. Huge Potential with Covid 2nd waveCurrently KNOS is in an ascending bull flag. Why KNOS has huge potential within the months to come: Their air filtration technology fully removes harmful allergens, bacteria, viruses (including the flu) and even gases from your breathing space. This product far outperforms the outdated 1940’s technology of a HEPA filter, and eliminates the shortcomings of any other air Kronos owns 12 patents in total, all focused on air filtration, and the removal of harmful bacteria, allergens and viruses from the breathing space. Patents: US 7,150,780 B2 US 6,937,455 B2 US 6,919,698 B2 US 6,727,657 B2 US 7,122,070 B1 US 6,963,479 B2 US 7,053,565 B2 US 6,664,741 B1 US 2010/0047115 A1 US 2009/0022340 A1 US 2010/0065510 A1 US 2010/0065510 A1 June 18th, 2020, Kronos signs deal to acquire US based leader in electronics manufacturing industry including its 85,000 square foot manufacturing facility. Kronos announced that it has signed a “Letter of Intent” with a privately held company to acquire a manufacturing facility for its consumer electronics products operations. The Company plans to manufacture a variety of electronic products, including medical ventilators and other vitally necessary medical equipment in addition to its flagship air purification products. Having their own manufacturing facility would not only help them to scale production to address growing sales and product line expansion, but also to develop new products and bring those to market much faster under a more efficient and controllable cost structure. June 29th, 2020 Kronos starts taking pre-orders for air purification products.
OTC:KNOSLong
by OttersOnly
3
NIO - Low Valuation Compared to TeslaNIO Limited designs, manufactures, and sells electric vehicles in the People's Republic of China, Hong Kong, the United States, the United Kingdom, and Germany. The company offers five, six, and seven-seater electric SUVs. It is also involved in the provision of energy and service packages to its users; marketing, design, and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. In addition, the company offers charging solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Mobile, a mobile charging service through charging trucks; Public Charger, a public fast charging solution; and Power Express, a 24-hour on-demand pick-up and drop-off charging service. Further, it provides value-added services, such as statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance services; courtesy car services during lengthy repairs and maintenance; and roadside assistance, as well as data packages. NIO Limited has a strategic collaboration with Mobileye N.V. for the development of automated and autonomous vehicles; and collaboration agreements with various manufacturers for the manufacture of ES8, a six or seven-seater high-performance electric SUV. The company was formerly known as NextEV Inc. and changed its name to NIO Limited in July 2017. NIO Limited was founded in 2014 and is headquartered in Shanghai, China. NIO, which was founded in 2014, currently offers two premium electric SUVs ES8 and ES6, which are priced starting at about $51k. The company is also innovating in the self-driving technology space and offers a battery swap service. Nio delivered 20,565 cars last year, marking an 81% year-over-year increase. NIO is growing faster than Tesla due in part to the large China population. While NIO is in the earlier phases of growth with revenue expanding 56% last year and growth likely to accelerate in 2020, Tesla sales grew by just 15% last year and could potentially slow in 2020. Overall, compared to Tesla, NIO’s has a faster growth ratio and lower valuation multiple which makes a case for the stock. So, at its current price, NIO is in my opinion a buy. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
Trend reversal? Targets ST 3.64p/5.6p MT- 8.48p LT - 15pAfter seller exhaustion comes the bulls and I believe we are very close of a turn here which will take us to 3.64p-5.6p with right news. I believe seller should be or is out as bulls come in. Permit should be coming any day now after xmas holidays. Gap to fill at 5.6-5.8p! Medium term I can see us touching 8.48p Long term 15p copper price doing well as of late BoD have also skin in the game & ASIPAC having a considerable amount invested in the business.
LSE:ARSLong
by vcm11
10
90p - 118p swing trade 200p+ LT investmentInterview on 28% increase in revenues from H1 Results. Confirms on track for £15.8m Revenues! Confirms new product launches to come - these not in the forecasted numbers! Excellent visibility of business (just go online, or walk into Boots or Superdrugs) ✅ Growing Revs, Growing Profits, Growing Cash, No Debts = Limited Risk, Decent Reward potential Bought more at 61p to my investment holding. Reason for last big dip was due to Haris leaving the business & selling his shares, we got now a new Chairman! 90p 1st target 118p 2nd target Long term target 200p! (same as broker target although they will revise once this new product comes in)
ILong
by vcm11
Bullish Sector - 5G Play, Golden CrossNokia Corporation engages in the network and technology businesses worldwide. The company operates in four segments: Ultra Broadband Networks, Global Services, IP Networks and Applications, and Nokia Technologies. It focuses on mobile radio including macro radio, small cells, and cloud native radio solutions for communications service providers and enterprises; and provides network planning and optimization, network implementation, and systems integration, as well as company-wide managed services. The company also offers fixed networking solutions, such as copper and fiber access products, solutions, and services. In addition, it provides network infrastructure and professional services for mobile networks; and managed services for the fixed, mobile, Internet protocol (IP), and optical domains. Further, the company offers network planning, implementation, operation, and maintenance services. Additionally, it provides IP/optical networking solutions, including IP routing and optical transport systems, software, and services; software solutions, such as customer experience management, network operations and management, communications and collaborations, policy and charging, as well as Cloud, IoT, security, and analytics platforms; and submarine networks and radio frequency systems. The company has a strategic collaboration with Microsoft. Nokia Corporation was founded in 1865 and is headquartered in Espoo, Finland. Nokia continues receiving 5G contracts. On the Daily Chart, the 50-Day MA is ready to Cross up and over the 200-Day MA, Bullish I think NOK has a shot at reversing its downward trend real soon especially if the USA takes an ownership in the company like many White House officials have been talking about possibly doing to stop China. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NOKLong
by HotCharts
1
Merger Approved - Huge Drug Company & Dirt Cheap Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS. The company also provides prescription products, such as EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases. In addition, it markets OTC products, including Cold-EEZE, MidNite, Vivarin, Brufen, CB12, and EndWarts. The company offers its products to therapeutic areas, such as cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's health. Its customers include retail pharmacies, wholesalers and distributors, payers, and insurers and governments, as well as institutions, such as hospitals. Mylan N.V. has collaboration and license agreements with Pfizer Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; Fujifilm Kyowa Kirin Biologics Co. Ltd; and Revance Therapeutics, Inc. The company was founded in 1961 and is based in Hatfield, the United Kingdom. Today, news that the merger with Upjohn was approved hit the news wires. www.bizjournals.com Mylan is in my opinion, one of the cheapest drug stocks in the sector at current levels. The stock currently trades at only 4x projected 2020 and 2021 earnings. The stock should be upwards of $25 to $30 a share with the merger approval. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
MLong
by HotCharts
Bullish Charts - Above the Cloud, Ready to Spike, Zika VirusBioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing BCX7353, an oral serine protease inhibitor and oral dose formulation that is in Phase III clinical trials to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in preclinical trials to treat fibrodysplasia ossificans progressive; and Galidesivir, an RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. Daily Chart: Volume: Bullish PMO Turning Up, Bullish MACD Turning Up, Bullish RSI: Bullish Stochastic: Bullish OBV: Bullish Accumulation: Bullish Sector: Bullish Closed above the cloud on Friday - Bullish On 06/10/2020, Company reported Galidesivir stopped the Zika virus replication. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:BCRXLong
by HotCharts
COVID-19 Vaccine, 1st Effective Drug, USA Secures 500,000 DosesHHS secures 500,000 doses of remdesivir. The Trump administration has secured 500,000 doses of remdesivir, the first drug shown to be effective at treating hospitalized coronavirus patients, ensuring these doses will be for U.S. use. This could mean huge profits for GILD. Indicators are starting to turn up, Bullish. Daily Chart is turning Bullish. I think if the stock breaks above the $77.00 range, it's going to spike. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
4
Bullish Charts - Golden Cross, Possible BuyoutCloudera, Inc. provides a suite of data analytics and management products in the United States, Europe, and Asia. The company operates through two segments, Subscription and Services. It offers Cloudera Enterprise Data Hub that allows companies to execute various analytic functions against a shared set of governed and secures data in public and private clouds, and data centers; Cloudera Data Warehouse, a hybrid cloud solution for self-service analytics; Cloudera Data Science and Engineering enables users to streamline, simplify, and scale big data processing; and Cloudera Operational DB that enables stream processing and real-time analytics on continuously changing data. The company also provides Hortonworks Data Platform, a data management platform that helps organizations to securely store, process, and analyze various data assets; Cloudera DataFlow, a data platform that collects, curates and analyzes data; Cloudera Data Science Workbench that enables self-service data science for the enterprise; and Cloudera Altus, a platform-as-a-service offering In addition, it offers Cloudera SDX, a solution that enables common security, governance, lineage, and metadata management for multiple analytics functions; and Cloudera Workload XM, an analytic workload experience management cloud service. Further, the company provides consulting, professional, and education services. It serves corporate enterprises and public sector organizations primarily through its direct sales force. The company was founded in 2008 and is headquartered in Palo Alto, California. Daily Chart: Volume: Bullish PMO: Bullish MACD: Bullish RSI: Bullish Stochastic: Bullish OBV: Bullish Accumulation: Bullish Sector: Bullish 50-Day MA just crossed the 100-Day MA and the 200-Day MA - Bullish Search through the recent news, there has been a lot of talk about Cloudera being bought for as high as $18.00 a share. IBM was mentioned as a potential buyer of the company. Market got crushed today, Cloudera was up. - Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
CLong
by HotCharts
Bullish Charts - In-Home COVID-19 TestCo-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah. Daily Chart MACD, RSI & STOCHASTIC are turning up, Bullish Volume is also picking up steam. On 06/09/2020, CODX announced the company will be added to the Russell 2000 and 3000 Indexes On 05/28/2020, Analysts set price targets at $30 and $36 On 05/26/2020, CODX said its Logix Smart Covid-19 test kit was used to demonstrate that the SARS-CoV-2 virus can be detected in cancer tissue of coronavirus patients. On 05/18/2020, Price Target Raised to $35.00 The stock looks like it's on the verge of breaking out much higher. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:CODXLong
by HotCharts
Bullish Charts - Gold at 8 Year High, 2nd Largest Mining Co.Barrick Gold Corporation engages in the exploration, mine development, production, and sale of gold and copper properties. It has ownership interests in producing gold mines that are located in Argentina, Canada, Côte d'Ivoire, the Democratic Republic of Congo, Dominican Republic, Mali, Papua New Guinea, Tanzania, and the United States. The company also has ownership interests in producing copper mines located in Chile, Saudi Arabia, and Zambia; and various other projects located throughout the Americas and Africa. Barrick Gold Corporation was founded in 1983 and is headquartered in Toronto, Canada. Daily Chart Indicators: Volume: Bullish PMO: Bullish MACD: Bullish OBV: Bullish Stochastic: Bullish Sector: Bullish Barrick is getting ready to spike up above the cloud. I think if it breaks above $26 to $26.50, it's going to run. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:GOLDLong
by HotCharts
Bullish Charts - Daily Chart / Indicators look BullishI just got done looking at the GOLDBEES.IN & GOLD daily charts, the charts looks amazing. Indicators: Volume: Bullish PMO: Bullish MACD: Bullish RSI: Bullish Stochastic: Bullish Accumulation: Bullish Sector: Bullish We are trending up above the cloud. I think any pullback will be short lived as seen with today's decline, Bulls came in and started buying. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
TVC:GOLDLong
by HotCharts